These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17408540)

  • 1. [Rituximab for treatment of patients with systemic autoimmune diseases].
    García Hernández FJ; Ocaña Medina C; González León R; Garrido Rasco R; Colorado Bonilla R; Castillo Palma MJ; Sánchez Román J
    Med Clin (Barc); 2007 Mar; 128(12):458-62. PubMed ID: 17408540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].
    Lehembre S; Macario-Barrel A; Musette P; Carvalho P; Joly P
    Ann Dermatol Venereol; 2006 Jan; 133(1):53-5. PubMed ID: 16495854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with rituximab of autoimmune disease: results from AADEA's registry].
    Callejas Rubio JL; Camps MT; García-Hernández F;
    Med Clin (Barc); 2008 Jan; 130(2):79. PubMed ID: 18221681
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
    Aries PM; Hellmich B; Voswinkel J; Both M; Nölle B; Holl-Ulrich K; Lamprecht P; Gross WL
    Ann Rheum Dis; 2006 Jul; 65(7):853-8. PubMed ID: 16269425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
    Ilizaliturri-Guerra O; Uriarte-Botello R; Pineda-Sic RÁ; Serna-Peña G; Garza-Elizondo MA; Galarza-Delgado DÁ; Leal-Bramasco AS; Elizondo-Solís CV; Santoyo-Fexas L; Villarreal-Alarcón MÁ
    Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
    Joshi L; Lightman SL; Salama AD; Shirodkar AL; Pusey CD; Taylor SR
    Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
    de Menthon M; Cohen P; Pagnoux C; Buchler M; Sibilia J; Détrée F; Gayraud M; Khellaf M; Penalba C; Legallicier B; Mouthon L; Guillevin L
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S63-71. PubMed ID: 21586199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description of therapeutic strategies in severe systemic lupus erythematosus-associated immune thrombocytopenia: a retrospective cohort study of response and relapse.
    Cimé-Aké E; Barrera-Vargas A; Demichelis-Gómez R; Ramírez-Alemón M; Rull-Gabayet M
    Clin Rheumatol; 2024 Aug; 43(8):2521-2532. PubMed ID: 38916764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective B cell depletion with rituximab in the treatment of autoimmune diseases.
    Kneitz C; Wilhelm M; Tony HP
    Immunobiology; 2002 Dec; 206(5):519-27. PubMed ID: 12607727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.
    Omdal R; Wildhagen K; Hansen T; Gunnarsson R; Kristoffersen G
    Scand J Rheumatol; 2005; 34(3):229-32. PubMed ID: 16134730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004).
    Scheinberg M; Hamerschlak N; Kutner JM; Ribeiro AA; Ferreira E; Goldenberg J; Kiss MH; Chahade WH
    Clin Exp Rheumatol; 2006; 24(1):65-9. PubMed ID: 16539821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
    Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
    Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis.
    Bachmeyer C; Cadranel JF; Demontis R
    Nephrol Dial Transplant; 2005 Jun; 20(6):1274. PubMed ID: 15840659
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
    Henes JC; Fritz J; Koch S; Klein R; Horger M; Risler T; Kanz L; Koetter I
    Clin Rheumatol; 2007 Oct; 26(10):1711-5. PubMed ID: 17502992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.